Natco Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹647.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 52.51 per cent from ₹1,363.00 crore. This corresponds to a year-on-year *(YoY) growth of 36.33 per cent.
Operating Profit
Operating Profit stands at ₹158.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 72.60 per cent from ₹579.20 crore. This corresponds to a year-on-year *(YoY) growth of 309.02 per cent.
PBDT
PBDT stands at ₹218.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 67.24 per cent from ₹666.10 crore. This corresponds to a year-on-year *(YoY) growth of 3.56 per cent.
Profit Before Tax
Profit Before Tax stands at ₹172.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.97 per cent from ₹613.70 crore. This corresponds to a year-on-year *(YoY) growth of 5.07 per cent.
Net Profit
Net Profit stands at ₹151.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.79 per cent from ₹517.90 crore. This represents a 14.27 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Natco Pharma Ltd News
Natco Pharma Ltd Earnings
- YOY
- QOQ
Natco Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natco Pharma Ltd Research Reports
Natco Pharma Ltd Financial Reports
Natco Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natco Pharma | -0.34% | 1.14% | 8.40% | 24.01% | 35.03% | 37.52% |
| Sai Life | -1.57% | -1.34% | 7.11% | 12.72% | 26.85% | 53.96% |
| Piramal Pharma | -0.92% | 0.63% | 7.73% | 15.72% | -5.52% | -12.74% |
| Neuland Labs. | -0.16% | 2.11% | 17.89% | 30.03% | -1.80% | 54.09% |
| Pfizer | -0.12% | -0.36% | -3.61% | -5.70% | -6.62% | -15.67% |
| Astrazeneca Phar | -6.56% | -2.14% | -0.75% | -4.59% | -7.23% | 6.42% |
| OneSource Speci. | -1.54% | -4.02% | 1.39% | 36.30% | 16.12% | 1.63% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & Chief Executive Officer : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh